Latest News - Elevance Health
Top Corporates Hub
Elevance Health
Elevance Health Reinstated at Inline by Evercore ISI: Is the Medicare Advantage Bounce Already Priced In?
08.04.2026 13:23
Elevance Health (NYSE:ELV) stock surged this week after the Centers for Medicare & Medicaid Services finalized a 2.48% Medicare Advantage payment rate increase for 2027, coming in above the high end of the 1% to 2% improvement the market was expecting. Elevance Health shares are now up to $315. That’s meaningful, but Wall Street is ... Elevance Health Reinstated at Inline by Evercore ISI: Is the Medicare Advantage Bounce Already Priced In?
This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
08.04.2026 09:25
Top Wall Street analysts changed outlook on top names. See complete rating changes, including upgrades and downgrades, on Benzinga's analyst ratings page.
Evercore ISI Group Initiates Coverage On Elevance Health with In-Line Rating, Announces Price Target of $345
08.04.2026 08:04
Evercore ISI Group analyst Elizabeth Anderson initiates coverage on Elevance Health (NYSE:ELV) with a In-Line rating and announces Price Target of $345.
A Look At Elevance Health (ELV) Valuation After CMS Releases 2027 Medicare Payment Rates
08.04.2026 00:24
Elevance Health (ELV) is back in focus after a 6% share price jump following the release of 2027 Medicare payment rates by the Centers for Medicare & Medicaid Services, alongside a broader rally in managed care stocks. See our latest analysis for Elevance Health. That CMS catalyst sits against a tougher backdrop, with a 1 year total shareholder return decline of 26.1% and a 3 month share price return decline of 15%, so the recent 7.7% 1 month share price gain suggests momentum is rebuilding...
Wondering what's happening in today's S&P500 pre-market session?
07.04.2026 12:35
The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
Stocks to Watch: UnitedHealth, Humana, Universal Music Group, Broadcom
07.04.2026 10:52
↗️ UnitedHealth (UNH), Humana (HUM), Elevance Health (ELV), CVS Health (CVS), Molina Healthcare (MOH), Centene (CNC): Shares of health and insurance companies rose premarket after the Trump administration said it would increase payments to Medicare insurers.
Will Elevance Health’s (ELV) Leadership Shuffle Refocus Its Core Advantage In Government Programs?
07.04.2026 10:11
On March 31, 2026, Elevance Health announced a broad slate of leadership appointments across its Health Benefits and Carelon divisions, reshaping oversight of government programs, clinical operations, analytics, growth, and finance. The concentration of senior talent in Carelon and government businesses highlights how Elevance is prioritizing operational execution and care coordination just as analysts brace for pressure in Medicare and Medicaid profitability. We’ll now examine how...
Wall Street Breakfast Podcast: Insurers Pop On Medicare Rate Hike
07.04.2026 06:49
Insurance stocks jump on Medicare Advantage rate boost: Humana, UnitedHealth, lead gains. SpaceX details IPO schedule; demand expected to break records. Amazon reduces its reliance on USPS.
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.
06.04.2026 21:05
Discover the top S&P500 movers in Monday's after-hours session and stay informed about the post-market dynamics.
Elevance Health Earnings Preview: What to Expect
06.04.2026 09:58
Elevance Health will release its first-quarter earnings later this month, and analysts anticipate a low double-digit profit dip.
Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report?
03.04.2026 16:10
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CMS Extension And Leadership Shakeup Give Elevance Health Time To Rebuild Returns
02.04.2026 12:12
Elevance Health (NYSE:ELV) received a last minute extension from the Centers for Medicare & Medicaid Services to correct risk adjustment data reporting issues tied to its Medicare Advantage plans. The CMS decision temporarily removes the threat of immediate sanctions that could have restricted new enrollments and affected member access. At the same time, Elevance announced leadership changes across its Health Benefits and Carelon units, aimed at sharpening execution in its services...
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges
13.03.2026 14:01
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 3.8% over the past six months, almost identical to the S&P 500.
Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $350
11.03.2026 09:17
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and lowers the price target from $413 to $350.
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation
09.03.2026 20:05
BURLINGTON, Mass., March 09, 2026--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts, which include the Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans are expected to become effec
2 Cash-Producing Stocks Worth Your Attention and 1 Facing Headwinds
09.03.2026 17:40
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
CMS Sanctions And Legal Probes Test Elevance Health Valuation Story
06.03.2026 12:08
CMS has announced plans to impose sanctions on Elevance Health (NYSE:ELV) that would suspend new enrollments in its Medicare Advantage plans. The potential suspension is tied to alleged noncompliance with federal risk adjustment data submission requirements for Medicare Advantage. At the same time, legal investigations have begun into possible securities fraud or unlawful business practices related to these regulatory issues. Elevance Health is a major player in US health insurance, with...
Why Elevance Health (ELV) Is Down 11.3% After Medicare Advantage Sanctions Threat And Community Push
06.03.2026 10:12
In late February and early March 2026, the Centers for Medicare & Medicaid Services notified Elevance Health of planned intermediate sanctions that could suspend new enrollment and certain marketing activities for its Medicare Advantage-Prescription Drug plans from March 31, citing past noncompliance with risk adjustment data submission requirements. At the same time, Elevance Health and the National Diaper Bank Network launched a year-long diaper access pilot for up to 9,000 families,...
Elevance Health and National Diaper Bank Network Launch National Pilot to Address Diaper Affordability and Improve Family Health
03.03.2026 15:00
INDIANAPOLIS, March 03, 2026--Elevance Health (NYSE: ELV) and the National Diaper Bank Network (NDBN) today announced a new national pilot program designed to expand access to diapers for families with infants and young children, helping reduce financial strain while generating evidence on how meeting basic material needs can improve maternal and child health outcomes.
Stellar Health Names Former Elevance Health Executive Raul Smith as Chief Financial Officer
03.03.2026 14:28
Stellar Health ("Stellar"), a healthcare technology company focused on revolutionizing value-based care, today announced the appointment of Raul Smith as Chief Financial Officer. This move underscores Stellar's dedication to aligning incentives across the care continuum, ensuring that health plans and providers can seamlessly translate value-based care strategies into quantifiable clinical and financial success.